Bio-Techne (FRA:TE1) Ending Cash Position : €130 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Bio-Techne Ending Cash Position?

Bio-Techne's Ending Cash Position for the quarter that ended in Mar. 2025 was €130 Mil.

Bio-Techne's quarterly Ending Cash Position increased from Sep. 2024 (€169 Mil) to Dec. 2024 (€170 Mil) but then declined from Dec. 2024 (€170 Mil) to Mar. 2025 (€130 Mil).

Bio-Techne's annual Ending Cash Position increased from Jun. 2022 (€163 Mil) to Jun. 2023 (€167 Mil) but then declined from Jun. 2023 (€167 Mil) to Jun. 2024 (€141 Mil).

Bio-Techne Ending Cash Position Historical Data

The historical data trend for Bio-Techne's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Ending Cash Position Chart

Bio-Techne Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Ending Cash Position

Get a 7-Day Free Trial

130.20

165.25

163.25

166.67

141.01

Bio-Techne Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															128.72	141.01	168.97	169.56	130.12

Bio-Techne Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bio-Techne's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	167.751	+	-26.737
	=	141

Bio-Techne's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	164.234	+	-34.114
	=	130

Bio-Techne Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (FRA:TE1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

TECH:USA T1CH34:Brazil

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines